We are live on ! Find out more
BCP

BlackBarn Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 63.92%
This Fund
S&P 500
This Quarter Est. Return
-4.87%
1 Year Est. Return
+63.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.57B
AUM Growth
-$248M
Cap. Flow
+$61.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
92.75%
Holding
24
New
7
Increased
7
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
ACLS icon
Axcelis
ACLS
+$26.8M
2
NXT icon
Nextpower Inc. Common Stock
NXT
+$16M
3
CCOI icon
Cogent Communications
CCOI
+$14M
4
RH icon
RH
RH
+$10.4M
5
EGBN icon
Eagle Bancorp
EGBN
+$9.02M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.33%
2 Healthcare 11.41%
3 Financials 2.59%
4 Technology 2.48%
5 Communication Services 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$699M 44.47%
1,250,000
-1,250,000
-50% -$735M
HYG icon
2
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.3B
$434M 27.6%
+5,500,000
New +$437M
TSLA icon
3
PUT
Tesla
TSLA
$1.44T
$130M 8.24%
500,000
+250,000
+100% +$83.3M
ROIV icon
4
Roivant Sciences
ROIV
$29.5B
$47.9M 3.05%
4,750,000
+625,000
+15% +$6.76M
UNH icon
5
UnitedHealth
UNH
$340B
$34.6M 2.2%
66,000
+6,000
+10% +$3.07M
MOH icon
6
Molina Healthcare
MOH
$10.7B
$31.5M 2%
95,500
-1,500
-2% -$453K
AMRX icon
7
Amneal Pharmaceuticals
AMRX
$5.92B
$24.1M 1.54%
2,881,654
+31,654
+1% +$264K
ACLS icon
8
Axcelis
ACLS
$3.5B
$23.9M 1.52%
480,441
+424,444
+758% +$26.8M
PRVA icon
9
Privia Health
PRVA
$2.61B
$16.8M 1.07%
750,000
+86,603
+13% +$2.01M
WBA
10
PUT
DELISTED
Walgreens Boots Alliance
WBA
$16.8M 1.07%
+1,500,000
New +$16.3M
TEVA icon
11
Teva Pharmaceuticals
TEVA
$43.2B
$16.1M 1.03%
1,050,000
NXT icon
12
Nextpower Inc. Common Stock
NXT
$12.6B
$15.2M 0.96%
+360,000
New +$16M
DHC
13
Diversified Healthcare Trust
DHC
$1.82B
$15M 0.95%
6,250,000
BRBS icon
14
Blue Ridge Bankshares
BRBS
$367M
$14.1M 0.9%
4,316,706
-49,556
-1% -$169K
CCOI icon
15
Cogent Communications
CCOI
$478M
$11.6M 0.74%
+190,000
New +$14M
ABUS icon
16
Arbutus Biopharma
ABUS
$1.01B
$8.17M 0.52%
2,341,871
EGBN icon
17
Eagle Bancorp
EGBN
$841M
$7.98M 0.51%
+380,000
New +$9.02M
BVFL icon
18
BV Financial
BVFL
$177M
$7.32M 0.47%
480,000
RH icon
19
RH
RH
$2.54B
$7.03M 0.45%
+30,000
New +$10.4M
FBLA
20
FB Bancorp
FBLA
$232M
$6.81M 0.43%
604,700
+204,700
+51% +$2.34M
HBNC icon
21
Horizon Bancorp
HBNC
$1.02B
$4.52M 0.29%
+300,000
New +$4.87M
MODV
22
DELISTED
ModivCare
MODV
$132K 0.01%
100,577
CHRD icon
23
Chord Energy
CHRD
$8.31B
-140,000
Closed -$16.4M
CIVI
24
DELISTED
Civitas Resources
CIVI
-380,000
Closed -$17.4M

Similar funds

BlackBarn Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, BlackBarn Capital Partners held 24 positions worth $1.57B, down 14% from $1.82B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

BlackBarn Capital Partners deployed $61.2M of net new capital in Q1 2025, opening 7 new positions and adding to 7 existing holdings. Its largest new stake was Nextpower Inc. Common Stock: 360,000 shares worth $15.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 87% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Molina Healthcare, an estimated $453K trimmed.

  • BlackBarn Capital Partners's largest Q1 2025 buy was Nextpower Inc. Common Stock: 360,000 shares worth $15.2M.
  • BlackBarn Capital Partners added most to Axcelis in Q1 2025, an estimated $26.8M increase.
  • BlackBarn Capital Partners's biggest Q1 2025 reduction was Molina Healthcare, cutting an estimated $453K.
  • BlackBarn Capital Partners fully exited Civitas Resources in Q1 2025, selling an estimated $17.4M.
  • BlackBarn Capital Partners's ten largest holdings make up 93% of its $1.57B portfolio in Q1 2025.
  • BlackBarn Capital Partners opened 7 new positions and closed 2 in Q1 2025.
  • BlackBarn Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.57B.

Based on BlackBarn Capital Partners's 13F filing for Q1 2025, filed 14 May 2025.